Drug repurposing in amyotrophic lateral sclerosis (ALS).
Carroll E. et al, (2025), Expert Opin Drug Discov, 1 - 18
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor.
O'Brien DP. et al, (2025), J Proteome Res, 24, 479 - 490
Identification and characterization of human KALRN mRNA and Kalirin protein isoforms.
Mould AW. et al, (2024), Cereb Cortex, 34
The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research.
Sanfelice D. et al, (2024), Nucleic Acids Res
Covalent Inhibitors of S100A4 Block the Formation of a Pro-Metastasis Non-Muscle Myosin 2A Complex.
Giroud C. et al, (2024), J Med Chem, 67, 18943 - 18956
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Balıkçı E. et al, (2024), J Med Chem, 67, 7245 - 7259
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
Xiong Y. et al, (2024), J Med Chem, 67, 5837 - 5853
Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.
Bradshaw WJ. et al, (2024), Structure, 32, 453 - 466.e6
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
Bashore FM. et al, (2024), PLoS One, 19
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease.
Du Y. et al, (2023), J Biol Chem, 299
The X-linked histone demethylases KDM5C and KDM6A as regulators of T cell-driven autoimmunity in the central nervous system.
Fazazi MR. et al, (2023), Brain Res Bull, 202
Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides.
O'Brien DP. et al, (2023), Mol Cell Proteomics, 22
Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2
Bradshaw WJ. et al, (2023)